Pfizer 2Q mixed, maintains 2013 outlook
Pfizer's second-quarter net income more than quadrupled, helped by the sale of its animal health business. The world's second-largest drugmaker beat Wall Street's earnings expectations, though revenue continued to decline ...
Jul 30, 2013
0
0